Skip to main content

OMER Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Omeros Corporation News

The Case For a Biotech Snapback

After a challenging year, shares of biotech companies could see rebound following tax loss selling, Bret Jensen says.

Reflecting on 9/11: Cramer's 'Mad Money' Recap

Jim Cramer says he believes we are today better prepared for both the terror and the financial attacks that America endured on 9/11.

Cypress Semiconductor, Omeros, Zuora: 'Mad Money' Lightning Round

Jim Cramer weighs in on Cypress Semiconductor, Omeros, Zuora, Kemet, Leidos, Raytheon, and Skyworks Solutions.

New Budget Deals Big Pharma a Blow on Medicare Part D, but Omeros Scores

Despite lobbying hard for changes, the pharmaceutical industry is going to cover more costs regarding Medicare Part D in the $1.3 trillion budget that needs to pass by Friday.

Omeros Shares Lower After Completing Stock Offering - Biotech Movers

The Seattle firm said Aug. 21 it completed an underwritten public offering of 3 million shares priced at $22.75 apiece.

Breaking News

Tesla Stock Slides On Reports of California Layoffs, Office Closure

Tesla has reportedly closed its San Mateo office, and laid off 200 employees, as it begins a wave of cost cuts throughout the carmaker's global operations.

Disney Stock Lower As Board Extends Contract of CEO Bob Chapek

"Bob is the right leader at the right time for The Walt Disney Company, and the board has full confidence in him and his leadership team,' said Disney chair Sue Arnold.

Bed Bath & Beyond Stock Plunges On Q1 Loss, CEO Mark Tritton Exit

"After thorough consideration, the Board determined that it was time for a change in leadership," said independent director Harriet Edelman.

FedEx Stock Slides As Ground Margin Forecast Highlights Inflation Challenge

"Our strategy is focused on driving yields, expanding margins, and elevating returns through profitable growth and capital efficiency," said new CEO Raj Subramaniam.